Patents by Inventor Peter Schwind

Peter Schwind has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020155961
    Abstract: The present invention relates to contact lens care product comprising dexpanthenol. The invention similarly relates to the usage of a contact lens care compositions of this kind for cleaning and optionally disinfecting contact lenses.
    Type: Application
    Filed: January 11, 2002
    Publication date: October 24, 2002
    Inventors: Peter Schwind, Anton Scherer
  • Patent number: 6440411
    Abstract: The present invention is directed to an ophthalmic product comprising, as a colouring agent, the extract of an alga. A preferred class of alga the extract of which is useful in the present invention is blue alga (Spirulina type), more preferred it is Japanese blue alga (Spirulina platensis). The ophthalmic product is preferably a contact lens care product.
    Type: Grant
    Filed: April 19, 2001
    Date of Patent: August 27, 2002
    Assignee: Novartis, AG
    Inventors: Anton Scherer, Peter Schwind
  • Publication number: 20010033843
    Abstract: The present invention is directed to an ophthalmic product comprising, as a coloring agent, the extract of an alga. A preferred class of alga the extract of which is useful in the present invention is blue alga (Spirulina type), more preferred it is Japanese blue alga (Spirulina platensis). The ophthalmic product is preferably a contact lens care product.
    Type: Application
    Filed: April 19, 2001
    Publication date: October 25, 2001
    Inventors: Anton Scherer, Peter Schwind
  • Patent number: 6203706
    Abstract: Described is a method and reagent kit for the detection of an analyte in a sample liquid by agglutination, wherein the sample liquid is contacted with an agglutination reagent in a reaction vessel that contains an inert matrix to form a reaction mixture that is then subjected to centrifugation. The reaction between the analyte and the agglutination reagent is determined based upon the penetration of the agglutination reagent into the inert matrix. The agglutination reagent includes synthetic particles having an average diameter and specific density chosen such that the particles' sedimentation behavior towards the matrix is essentially the same as that of erythrocytes under the same centrifugal conditions. Preferably, the surfaces of the synthetic particles have ligand molecules immobilized thereon for binding to the analyte.
    Type: Grant
    Filed: December 16, 1997
    Date of Patent: March 20, 2001
    Assignee: Stiftung fur Diagnostische Furschung
    Inventors: Peter Schwind, David Bashforth, Roderick N. Hobbs, Graham Margetts, Michael J. Marshall, Mark J. J. Roberts